CureVac GmbH Product Segmentation & Forecast - 2015

1
Cure Vac GmbH -Product Pipeline Review - 2015
No. Pages 44
Published on October - 2015
2
.
Report Overview
About Cure Vac GmbH Product Pipeline Review
2015 Global Markets Directs, Cure Vac GmbH
Product Pipeline Review - 2015, provides an
overview of the Cure Vac GmbHs pharmaceutical
research and development focus. This report
provides comprehensive information on the current
therapeutic developmental pipeline of Cure Vac
GmbHs, complete with comparative analysis at
various stages, therapeutics assessment by drug
target, mechanism of action (MoA), route of
administration (RoA) and molecule type. It also
reviews latest updates, and featured news and
press releases, along with special features on
late-stage and discontinued projects. Global
Markets Directs report features investigational
drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is
built using data and information sourced from
Global Markets Directs proprietary databases,
Company/University websites, SEC filings,
investor presentations and featured press
releases from company/university sites and
industry-specific third party sources, put
together by Global Markets Directs team. Get
Full Details On http//www.researchbeam.com/cure
vac-gmbh-product-pipeline-review-2015-market

3
.
Report Overview
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Scope The report provides
brief overview of Cure Vac GmbH including
business description, key information and facts,
and its locations and subsidiaries The report
reviews current pipeline of Cure Vac GmbHs human
therapeutic division and enlists all their major
and minor projects
4
.
Report Overview
The report features product description and
descriptive mechanism of action for key pipeline
products along with the products developmental
history and major milestones Special feature on
out-licensed and partnered product portfolio The
report summarizes all the dormant and
discontinued pipeline projects Latest company
statement Latest news and deals relating to the
Cure Vac GmbHs pipeline products   Reasons to
buy Evaluate Cure Vac GmbHs strategic position
with total access to detailed information on its
product pipeline Assess the growth potential of
Cure Vac GmbH in its therapy areas of
focus Identify new drug targets and therapeutic
classes in the Cure Vac GmbHs RD portfolio and
develop key strategic initiatives to reinforce
pipeline in those areas Exploit in-licensing
opportunities by identifying windows of
opportunity to fill portfolio gaps
5
Report Overview

• Develop strategic initiatives by understanding
  the focus areas of Cure Vac GmbH and exploit
  collaboration and partnership opportunities
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by
  identifying the most promising pipeline of Cure
  Vac GmbH
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Explore the dormant and discontinued projects of
  Cure Vac GmbH and identify potential
  opportunities in those areas
• Avoid Intellectual Property Rights related issues

6
Table Of Contents
List of Tables 5List of Figures 5CureVac GmbH
Snapshot 6CureVac GmbH Overview 6Key
Information 6Key Facts 6CureVac GmbH - Research
and Development Overview 7Key Therapeutic Areas
7CureVac GmbH - Pipeline Review 10Pipeline
Products by Stage of Development 10Pipeline
Products - Monotherapy 11Pipeline Products -
Partnered Products 12Partnered
Products/Combination Treatment Modalities
13Pipeline Products - Out-Licensed Products 14
7
Table Of Contents
Out-Licensed Products/Combination Treatment
Modalities 15CureVac GmbH - Pipeline Products
Glance 16CureVac GmbH - Clinical Stage Pipeline
Products 16Phase II Products/Combination
Treatment Modalities 16Phase I
Products/Combination Treatment Modalities
17CureVac GmbH - Early Stage Pipeline Products
18Preclinical Products/Combination Treatment
Modalities 18Discovery Products/Combination
Treatment Modalities 19CureVac GmbH - Drug
Profiles 20CV-9103 20Product Description
20Mechanism of Action 20RD Progress 20
8
Table Of Contents
CV-9104 22Product Description 22Mechanism of
Action 22RD Progress 22 CV-9201 23Product
Description 23Mechanism of Action 23RD
Progress 23CV-7201 24 Enquiry about this report
_at_ http//www.researchbeam.com/curevac-gmbh-product
-pipeline-review-2015-market/enquire-about-report

9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/curevac-gmbh-product-p
ipeline-review-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] E-MAIL
sales_at_researchbeam.com